Sterigenics in $805 Million Acquisition of Nordion
August 6, 2014
Cleary Gottlieb advised Sterigenics International in the antitrust aspects of its $805 million acquisition of one of its key suppliers, Nordion. Sterigenics is the leading global provider of outsourced contract sterilization services such as gamma sterilization using radioactive Cobalt-60 and a portfolio company of GTCR, and Nordion is a leading provider of radioactive isotopes (including Cobalt-60) for medical and sterilization applications. As a standalone business within Sterigenics, Nordion will remain headquartered in Ottawa, Canada, and will continue to operate under the Nordion name. The transaction was announced on March 28 and closed on August 6, 2014.